nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.448	1	CbGbCtD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.026	0.113	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0222	0.0959	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0212	0.0918	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0207	0.0895	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0183	0.0791	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0181	0.0782	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0169	0.073	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0149	0.0645	CbGpPWpGaD
Gallamine Triethiodide—Toxicity to various agents—Formoterol—chronic obstructive pulmonary disease	0.012	0.0375	CcSEcCtD
Gallamine Triethiodide—Toxicity to various agents—Arformoterol—chronic obstructive pulmonary disease	0.012	0.0375	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Roflumilast—chronic obstructive pulmonary disease	0.00816	0.0254	CcSEcCtD
Gallamine Triethiodide—Stomach ache—Salbutamol—chronic obstructive pulmonary disease	0.00763	0.0238	CcSEcCtD
Gallamine Triethiodide—Eyelid oedema—Arformoterol—chronic obstructive pulmonary disease	0.0068	0.0212	CcSEcCtD
Gallamine Triethiodide—Eyelid oedema—Formoterol—chronic obstructive pulmonary disease	0.0068	0.0212	CcSEcCtD
Gallamine Triethiodide—Sickness—Prednisolone—chronic obstructive pulmonary disease	0.0067	0.0209	CcSEcCtD
Gallamine Triethiodide—ACHE—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00354	0.0153	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00346	0.015	CbGpPWpGaD
Gallamine Triethiodide—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.00341	0.0106	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.00334	0.0145	CbGpPWpGaD
Gallamine Triethiodide—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00315	0.00983	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Arformoterol—chronic obstructive pulmonary disease	0.0031	0.00968	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Formoterol—chronic obstructive pulmonary disease	0.0031	0.00968	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.00933	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0029	0.0125	CbGpPWpGaD
Gallamine Triethiodide—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.0029	0.00903	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.00276	0.0086	CcSEcCtD
Gallamine Triethiodide—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0027	0.00843	CcSEcCtD
Gallamine Triethiodide—ACHE—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00268	0.0116	CbGpPWpGaD
Gallamine Triethiodide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00267	0.00832	CcSEcCtD
Gallamine Triethiodide—ACHE—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00251	0.0109	CbGpPWpGaD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.0025	0.0078	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00236	0.0102	CbGpPWpGaD
Gallamine Triethiodide—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00234	0.00731	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00695	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00695	CcSEcCtD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.00221	0.00957	CbGpPWpGaD
Gallamine Triethiodide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0022	0.00686	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00681	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00218	0.00943	CbGpPWpGaD
Gallamine Triethiodide—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.00218	0.00679	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.0067	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00214	0.00668	CcSEcCtD
Gallamine Triethiodide—Hypothyroidism—Prednisone—chronic obstructive pulmonary disease	0.0021	0.00656	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.00656	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00651	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00208	0.0065	CcSEcCtD
Gallamine Triethiodide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00208	0.00649	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.002	0.00623	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00199	0.0062	CcSEcCtD
Gallamine Triethiodide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.00598	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00191	0.00595	CcSEcCtD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00184	0.00796	CbGpPWpGaD
Gallamine Triethiodide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00178	0.00554	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00178	0.00768	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00173	0.0075	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00173	0.0054	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00539	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00539	CcSEcCtD
Gallamine Triethiodide—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.0053	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00528	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00524	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00167	0.00722	CbGpPWpGaD
Gallamine Triethiodide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.00515	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.0051	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00509	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00508	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00508	CcSEcCtD
Gallamine Triethiodide—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00506	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00505	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00499	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00499	CcSEcCtD
Gallamine Triethiodide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00494	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00494	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00157	0.0049	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.0049	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00489	CcSEcCtD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00155	0.00669	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.00479	CcSEcCtD
Gallamine Triethiodide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.00475	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.00474	CcSEcCtD
Gallamine Triethiodide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.00471	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00471	CcSEcCtD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.00149	0.00643	CbGpPWpGaD
Gallamine Triethiodide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00462	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00147	0.0046	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00458	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00458	CcSEcCtD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00144	0.00622	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.00447	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00433	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00431	CcSEcCtD
Gallamine Triethiodide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00428	CcSEcCtD
Gallamine Triethiodide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00428	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00425	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00136	0.00589	CbGpPWpGaD
Gallamine Triethiodide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00422	CcSEcCtD
Gallamine Triethiodide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00422	CcSEcCtD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00135	0.00583	CbGpPWpGaD
Gallamine Triethiodide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00419	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00409	CcSEcCtD
Gallamine Triethiodide—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00408	CcSEcCtD
Gallamine Triethiodide—Cough—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00408	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.0013	0.00564	CbGpPWpGaD
Gallamine Triethiodide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00404	CcSEcCtD
Gallamine Triethiodide—ACHE—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.00129	0.00556	CbGpPWpGaD
Gallamine Triethiodide—Cough—Montelukast—chronic obstructive pulmonary disease	0.00128	0.004	CcSEcCtD
Gallamine Triethiodide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00128	0.00399	CcSEcCtD
Gallamine Triethiodide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00399	CcSEcCtD
Gallamine Triethiodide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00398	CcSEcCtD
Gallamine Triethiodide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00398	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00398	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00398	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00397	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00397	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00396	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00396	CcSEcCtD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.00125	0.00543	CbGpPWpGaD
Gallamine Triethiodide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00125	0.0039	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00124	0.00388	CcSEcCtD
Gallamine Triethiodide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00386	CcSEcCtD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.00121	0.00523	CbGpPWpGaD
Gallamine Triethiodide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00376	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00376	CcSEcCtD
Gallamine Triethiodide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00376	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00374	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00373	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00373	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00371	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00371	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.0037	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00366	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00363	CcSEcCtD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.00115	0.00498	CbGpPWpGaD
Gallamine Triethiodide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00355	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00352	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.0035	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00349	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00348	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00348	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00343	CcSEcCtD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.0011	0.00475	CbGpPWpGaD
Gallamine Triethiodide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00341	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00336	CcSEcCtD
Gallamine Triethiodide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00335	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00106	0.0033	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.0033	CcSEcCtD
Gallamine Triethiodide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00329	CcSEcCtD
Gallamine Triethiodide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00329	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00329	CcSEcCtD
Gallamine Triethiodide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00327	CcSEcCtD
Gallamine Triethiodide—Pain—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00327	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00324	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00323	CcSEcCtD
Gallamine Triethiodide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00323	CcSEcCtD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00103	0.00447	CbGpPWpGaD
Gallamine Triethiodide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00103	0.0032	CcSEcCtD
Gallamine Triethiodide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00319	CcSEcCtD
Gallamine Triethiodide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00316	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00316	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00315	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00315	CcSEcCtD
Gallamine Triethiodide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00314	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000999	0.00311	CcSEcCtD
Gallamine Triethiodide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000997	0.00311	CcSEcCtD
Gallamine Triethiodide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000989	0.00308	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000981	0.00306	CcSEcCtD
Gallamine Triethiodide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000973	0.00303	CcSEcCtD
Gallamine Triethiodide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000973	0.00303	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000968	0.00302	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000968	0.00302	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000968	0.00302	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000968	0.00302	CcSEcCtD
Gallamine Triethiodide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000965	0.00301	CcSEcCtD
Gallamine Triethiodide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000957	0.00298	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000956	0.00298	CcSEcCtD
Gallamine Triethiodide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000956	0.00298	CcSEcCtD
Gallamine Triethiodide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000953	0.00297	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000953	0.00297	CcSEcCtD
Gallamine Triethiodide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000951	0.00297	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000948	0.00296	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000948	0.00296	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000938	0.00293	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000934	0.00291	CcSEcCtD
Gallamine Triethiodide—ACHE—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000933	0.00404	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000923	0.00399	CbGpPWpGaD
Gallamine Triethiodide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000919	0.00287	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000914	0.00285	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000914	0.00285	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000902	0.00281	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000902	0.00281	CcSEcCtD
Gallamine Triethiodide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000902	0.00281	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000884	0.00276	CcSEcCtD
Gallamine Triethiodide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000879	0.00274	CcSEcCtD
Gallamine Triethiodide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000879	0.00274	CcSEcCtD
Gallamine Triethiodide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000867	0.0027	CcSEcCtD
Gallamine Triethiodide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000867	0.0027	CcSEcCtD
Gallamine Triethiodide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000861	0.00268	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000852	0.00266	CcSEcCtD
Gallamine Triethiodide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000849	0.00265	CcSEcCtD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000841	0.00364	CbGpPWpGaD
Gallamine Triethiodide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000838	0.00261	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000838	0.00261	CcSEcCtD
Gallamine Triethiodide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00083	0.00259	CcSEcCtD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000821	0.00355	CbGpPWpGaD
Gallamine Triethiodide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000821	0.00256	CcSEcCtD
Gallamine Triethiodide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000818	0.00255	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.000817	0.00354	CbGpPWpGaD
Gallamine Triethiodide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000791	0.00247	CcSEcCtD
Gallamine Triethiodide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000779	0.00243	CcSEcCtD
Gallamine Triethiodide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000779	0.00243	CcSEcCtD
Gallamine Triethiodide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000772	0.00241	CcSEcCtD
Gallamine Triethiodide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000772	0.00241	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000772	0.00241	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000772	0.00241	CcSEcCtD
Gallamine Triethiodide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000767	0.00239	CcSEcCtD
Gallamine Triethiodide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000767	0.00239	CcSEcCtD
Gallamine Triethiodide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000763	0.00238	CcSEcCtD
Gallamine Triethiodide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000756	0.00236	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000756	0.00236	CcSEcCtD
Gallamine Triethiodide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000752	0.00234	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000749	0.00324	CbGpPWpGaD
Gallamine Triethiodide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000743	0.00232	CcSEcCtD
Gallamine Triethiodide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00229	CcSEcCtD
Gallamine Triethiodide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000733	0.00229	CcSEcCtD
Gallamine Triethiodide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000729	0.00227	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000729	0.00227	CcSEcCtD
Gallamine Triethiodide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000728	0.00227	CcSEcCtD
Gallamine Triethiodide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000728	0.00227	CcSEcCtD
Gallamine Triethiodide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.00226	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000716	0.0031	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000713	0.00222	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000704	0.00305	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.00214	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000682	0.00213	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000679	0.00212	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000676	0.00293	CbGpPWpGaD
Gallamine Triethiodide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000647	0.00202	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.000639	0.00276	CbGpPWpGaD
Gallamine Triethiodide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000634	0.00198	CcSEcCtD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00061	0.00264	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000609	0.00263	CbGpPWpGaD
Gallamine Triethiodide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000596	0.00186	CcSEcCtD
Gallamine Triethiodide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000567	0.00177	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000566	0.00245	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000551	0.00238	CbGpPWpGaD
Gallamine Triethiodide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000547	0.0017	CcSEcCtD
Gallamine Triethiodide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000546	0.0017	CcSEcCtD
Gallamine Triethiodide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00168	CcSEcCtD
Gallamine Triethiodide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000533	0.00166	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000527	0.00164	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000503	0.00157	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000499	0.00156	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000489	0.00152	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—APIP—chronic obstructive pulmonary disease	0.000487	0.00211	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000485	0.0021	CbGpPWpGaD
Gallamine Triethiodide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00047	0.00147	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000469	0.00203	CbGpPWpGaD
Gallamine Triethiodide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000468	0.00146	CcSEcCtD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000461	0.002	CbGpPWpGaD
Gallamine Triethiodide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000439	0.00137	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000433	0.00135	CcSEcCtD
Gallamine Triethiodide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000418	0.0013	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000418	0.0013	CcSEcCtD
Gallamine Triethiodide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000416	0.0013	CcSEcCtD
Gallamine Triethiodide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000416	0.0013	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000415	0.0018	CbGpPWpGaD
Gallamine Triethiodide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00124	CcSEcCtD
Gallamine Triethiodide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.00123	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000383	0.00119	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000381	0.00119	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000381	0.00119	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000369	0.0016	CbGpPWpGaD
Gallamine Triethiodide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00111	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000355	0.00154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000347	0.0015	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000346	0.00108	CcSEcCtD
Gallamine Triethiodide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000341	0.00106	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00033	0.00103	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000322	0.0014	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00032	0.00138	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	0.000314	0.00136	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000956	CcSEcCtD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000304	0.00132	CbGpPWpGaD
Gallamine Triethiodide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000948	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000947	CcSEcCtD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000302	0.00131	CbGpPWpGaD
Gallamine Triethiodide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000302	0.000942	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000292	0.00126	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000893	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000281	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000277	0.0012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000272	0.00118	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000261	0.00113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000259	0.00112	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000256	0.00111	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000252	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000246	0.00106	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000239	0.00104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000238	0.00103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000235	0.00102	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000235	0.00102	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000232	0.001	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000223	0.000967	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000209	0.000903	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000208	0.000901	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000207	0.000896	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000197	0.000852	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.000194	0.000841	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000189	0.00082	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000185	0.000799	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000183	0.000793	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000181	0.000783	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00018	0.000779	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000178	0.000772	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000174	0.000754	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000171	0.000742	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000169	0.000733	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000158	0.000684	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000155	0.000669	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000147	0.000636	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000144	0.000623	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.000616	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000139	0.000601	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000131	0.000566	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000119	0.000514	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000119	0.000514	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000117	0.000507	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000117	0.000506	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000116	0.000501	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000112	0.000484	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000112	0.000484	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000109	0.000472	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000106	0.00046	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.000448	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000102	0.000443	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.29e-05	0.000402	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.18e-05	0.000354	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.61e-05	0.000329	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	7.03e-05	0.000304	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.02e-05	0.000304	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	6.73e-05	0.000291	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.32e-05	0.000274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.27e-05	0.000271	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.74e-05	0.000248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.7e-05	0.000247	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.49e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.1e-05	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.19e-05	0.000182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.82e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.39e-05	0.000147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.22e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.07e-05	0.000133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.75e-05	0.000119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.53e-05	0.000109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.48e-05	0.000107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.08e-05	9e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.9e-05	8.24e-05	CbGpPWpGaD
